The Pathophysiology of Gestational Diabetes Mellitus
Open accessThe DOI matches its Crossref record; 163 of the 175 references it cites were found in a registry or an index; 42 of the 157 sources its claims cite were checked for support.
Abstract
Review of risk factors and maternal and child consequences of gestational diabetes mellitus.
Overview
CoChat Summary
TL;DR
This review summarizes the proposed pathophysiology of gestational diabetes mellitus (GDM), emphasizing that most cases involve β-cell dysfunction on a background of chronic insulin resistance. It argues that genetic, epigenetic, environmental, placental, inflammatory, oxidative, and microbiome-related factors likely interact, but the molecular mechanisms remain incompletely defined.
Key findings
- GDM affects approximately 14% of pregnancies worldwide according to 2017 IDF estimates, representing about 18 million births annually; the abstract also states approximately 16.5% worldwide.
- The review states that the vast majority (~80%) of GDM cases present as β-cell dysfunction on a background of chronic insulin resistance.
- In GDM, the rate of insulin-stimulated glucose uptake is reduced by 54% compared with normal pregnancy.
- The paper reports several outcome estimates: ~60% of women with prior GDM develop T2DM later in life, the yearly conversion risk is ~2 to 3%, and one study found a 63% increased risk of CVD among women with a history of GDM.
Methods
- This is a narrative review of the pathophysiology of GDM; it does not present a new experimental or clinical study.
- The paper synthesizes previously published evidence on glucose regulation in pregnancy, classification/prevalence, risk factors, consequences, and molecular mechanisms across tissues and systems.
- The analysis is descriptive and integrative, drawing on cited studies, including epidemiological studies, animal studies, mechanistic studies, and large cohort findings such as the HAPO Study (23,000 pregnant women).
Limitations
- The paper explicitly notes that epidemiological studies of risk factors for GDM are limited and typically afflicted by confounding factors, and that inconsistencies in diagnostic criteria and risk-factor measurement make studies hard to compare.
- The review states that molecular mechanisms underlying GDM are poorly defined and that greater understanding is required to develop effective treatments and prevention strategies.
- It is evident from the text that this is not an original empirical study, so it cannot establish causal effects on its own; it relies on secondary synthesis of heterogeneous prior literature.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
40 Valid · 2 Not valid · 86 Not checked · 24 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This loss of β-cell mass has been linked to epigenetic downregulation of pancreatic homeobox transcription factor (Pdx1), which is essential for normal β-cell differentiation in the embryo [79].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Partly supportedcites [79] Pinney, 2010, Epigenetic mechanisms in the development of type 2 diabetes, Trends Endocrinol. Metab. sourceExperimental — accuracy not yet measured
The ‘Chromatin Remodeling in the β-cell of IUGR rats’ section reports epigenetic repression of Pdx-1 in growth-restricted rats and describes its critical role in pancreatic development and β-cell differentiation. It does not link that repression to a loss of β-cell mass; it instead discusses β-cell secretory dysfunction, and notes that a milder Pdx-1 reduction in mice permits normal β-cell mass. Page numbers were not available in our copy. (LLM, conf=0.87)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Minor deficiencies in the β-cell machinery may only be exposed in times of metabolic stress, such as pregnancy [75].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Partly supportedcites [75] Prentki, 2006, Islet beta cell failure in type 2 diabetes, J. Clin. Investig. sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) proposes that one or a small number of β-cell defects can become weak links when β-cells must compensate for insulin resistance. That supports the general idea of deficiencies becoming consequential under increased demand. The review-series passage mentioning pregnancy (page unavailable) instead discusses maternal hyperglycemia as a risk factor for the offspring; it does not say pregnancy exposes a pre-existing β-cell deficiency in the pregnant person. (LLM, conf=0.85)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In addition, glucotoxicity is also thought to result in β-cell apoptosis over time [76].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Supportedcites [76] Ashcroft, 2017, Is Type 2 Diabetes a Glycogen Storage Disease of Pancreatic β Cells?, Cell MeTable source
The Abstract states that elevated plasma glucose leads to β-cell dysfunction and death and describes glycogen accumulation as contributing to this ‘glucotoxicity.’ The section ‘An Emerging Role for Glycogen in the Pathophysiology of Diabetes’ reports increased apoptosis in mouse β-cells with substantial glycogen stores. It qualifies the mechanism: apoptosis appears to result from glycogen accumulation rather than elevated glucose alone. Page numbers were not available in our copy. (LLM, conf=0.88)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“While potentially beneficial in times of famine, a mismatch between nutritional status in the womb and nutritional status once born can contribute to the development of obesity and metabolic disease [53,54].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction > 1.4. Risk Factors for Gestational Diabetes
What the sources say
- Not checked — no full text of the sourcecites [53] Vickers, 2000, Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition, Am. J. Physiol. Endocrinol. MeTable source
- Supportedcites [54] Desai, 2014, Maternal obesity and high-fat diet program offspring metabolic syndrome, Am. J. Obstet. Gynecol. source
The Methods (The Offspring; page not provided) describe groups with different high-fat-diet exposures during pregnancy and lactation, including both mismatched combinations. The Discussion (page not provided) reports increased offspring adiposity or obesity and metabolic disturbances in these groups. This supports the attributed claim that a prenatal–postnatal nutritional mismatch can contribute to obesity and metabolic disease. (LLM, conf=0.90)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“These individuals are more likely to have experienced hyperglycemia and β-cell fatigue even before birth, predisposing them to hyperglycemia during times of later metabolic stress, such as during pregnancy [55].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction > 1.4. Risk Factors for Gestational Diabetes
What the sources say
- Partly supportedcites [55] Portha, B., Chavey, A., and Movassat, J. (2011). Early-Life Origins of Type 2 Diabetes: Fetal Programming of the Beta-Cell Mass. Exp. Diabetes Res., 2011. sourceExperimental — accuracy not yet measured
Section 4 (page unavailable) links early-life stressors, including maternal overnutrition, to later endocrine pancreatic deficiency and says pregnancy can expose a latent low insulin response in female offspring. It also describes hyperglycemia during fetal and/or early postnatal life. The copy does not establish that overnourished individuals experienced β-cell fatigue before birth; the discussion relies substantially on animal models and does not isolate prenatal exposure for every case. (LLM, conf=0.84)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
81 more claims · 18 with their cited sources checked
Create a free account to see all 152 claims and to verify the 30 references still open.
- Probably not a substantial claim. 19
- It may state two separate claims as one. 54
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“An increased secretion of insulin-antagonistic hormones (placental hormones, cortisol) during pregnancy results in an increased insulin resistance, which, at the end of the third trimester, reaches a value similar to full-blown type 2 diabetes [9,42].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The mechanisms of β-cell hypertrophy and proliferation, resulting in a 300% increase in insulin secretion in the first two trimesters of physiological pregnancy, is insufficient to explain GDM [9,39].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Despite numerous studies, the pathogenesis of GDM remains unclear, and the results obtained so far indicate a complex mechanism of interaction of many genetic, metabolic and environmental factors [9].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
In the citing paper
“Under GDM, maternal insulin resistance increases the flux of glucose to the fetal circulation and contributes to increased fetal glucose uptake and growth [8].”
From Evaluating Traditional Chinese Medicine and Herbal Products for the Treatment of Gestational Diabetes Mellitus (2019) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ The Pathophysiology of Gestational Diabetes Mellitus > Abstract
“In most cases, this hyperglycemia is the result of impaired glucose tolerance due to pancreatic β-cell dysfunction on a background of chronic insulin resistance.”
§ The Pathophysiology of Gestational Diabetes Mellitus > 4. Conclusions
“in the majority of cases, pancreatic β-cells fail to compensate for a chronic fuel surfeit, leading to eventual insulin resistance, hyperglycemia, and an increased supply of glucose to the growing fetus.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The Pathophysiology of Gestational Diabetes Mellitus > Abstract
“GDM affects approximately 16.5% of pregnancies worldwide, and this number is set to increase with the escalating obesity epidemic.”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction
“According to the most recent (2017) International Diabetes Federation (IDF) estimates, GDM affects approximately 14% of pregnancies worldwide, representing approximately 18 million births annually [2].”
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100 · cited 1×
“Both red meat and animal protein decrease levels of Firmicutes, while high dietary fiber increase them [133].”
BackgroundChanges of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277 · cited 1×
“Increased gut permeability is thought to facilitate the movement of inflammatory mediators from the gut into the circulation, promoting systemic insulin resistance [134,136].”
BackgroundYamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238 · cited 1×
“Adiponectin enhances insulin signaling and fatty acid oxidation, and it inhibits gluconeogenesis [104].”
Backgroundβ-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s002 · Cited by 3,159
DeFronzo, R. A. (2009) · Diabetes · doi:10.2337/db09-9028 · Cited by 3,016
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961 · cited 1×
“Non-diabetic obese individuals exhibit adequate adipose tissue expansion in response to fuel surfeit, and therefore maintain healthy blood glucose concentrations, sufficient β-cell compensation, and avoid chronic insulin resistance [110,111].”
Background
Research works printed but not linked: 1
- Halliwell, B., and Gutteridge, J. (2007). Free Radicals in Biology and Medicine, Oxford University Press. [4th ed.].
Cited by
Items 301–400 of 1,810
Clinical potentials of ginseng polysaccharide for treating gestational diabetes mellitus
Zhao, X.-Y., Zhang, F., Pan, W., Yang, Y., & Jiang, X.-Y. (2021) · World Journal of Clinical Cases · doi:10.12998/wjcc.v9.i19.4959 · Cited by 21
A Systematic Review of the Prevalence of Gestational Diabetes in Norway
Behboudi-Gandevani, S., Parajuli, R., & Vaismoradi, M. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18041423 · Cited by 19
“In most patients with GDM, gestational hyperglycemia is the result of impaired glucose tolerance due to pancreatic β-cell dysfunction and post-receptor defects in the insulin signaling cascade, as the background of chronic insulin resistance [7,8].”
BackgroundMora-Ortiz, M., & Rivas‐García, L. (2024) · Open Research Europe · doi:10.12688/openreseurope.18026.1 · Cited by 39
Deleus, E., der Schueren, B. V., Devlieger, R., Lannoo, M., & Benhalima, K. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9092732 · Cited by 21
“When gestation progresses, a combination of maternal and placental hormones induce a state of insulin resistance [30].”
BackgroundCombined effects of air pollutants on gestational diabetes mellitus: A prospective cohort study
Liu, W., Lu, J., He, J., Zhang, L., Wei, D., Wang, C., Xiao, X., Xia, H., & Qiu, X. (2021) · Environmental Research · doi:10.1016/j.envres.2021.112393 · Cited by 20
Wang, X., Zhang, Y. P., Zheng, W., Wang, J., Wang, Y., Song, W., Liang, S., Guo, C., Ma, X., & Li, G. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1000296 · Cited by 24
“On the other hand, the occurrence of GDM can typically be afflicted by confounding factors, and many risk factors of GDM have been identified, such as advanced maternal age, obesity, excessive gestational weight gain, westernized diet, micronutrient deficiency, genetic polymorphism, and history of diseases with insuli…”
BackgroundHoffman, R. M., Newhouse, C. N., Chu, B., Stringer, J. S. A., & Currier, J. S. (2021) · Current HIV/AIDS Reports · doi:10.1007/s11904-020-00539-6 · Cited by 22
Sun, X., Sun, H. Y., & Li, P. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.09.004 · Cited by 23
Hill, T. G., & Hill, D. J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25074070 · Cited by 26
“The exception to this is pregnancy, where the increased maternal insulin resistance necessary to provide glucose flux across the placenta for the growing fetus necessitates a substantial adaptive increase in beta-cell mass and function [260,261].”
BackgroundPhaloprakarn, C., & Tangjitgamol, S. (2022) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-021-04352-w · Cited by 25
“This metabolic derangement is characterized by insufficient insulin secretion from pancreatic β-cells to compensate for pregnancy-induced physiologic insulin resistance [2].”
BackgroundMusa, O. A. H., Syed, A., Mohamed, A. M., Chivese, T., Clark, J. M., Furuya‐Kanamori, L., Xu, C., Toft, E. S., Bashir, M., Abou‐Samra, A., et al. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105546 · Cited by 27
Rademaker, D., van der Wel, A. W. T., van EEKELEN, R., Voormolen, D. N., de Valk, H. W., Evers, I. M., Mol, B. W., Franx, A., Siegelaar, S. E., van Rijn, B. B., et al. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15276 · Cited by 22
Sacha, C. R., Gopal, D., Liu, C., et al. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.03.005 · Cited by 19
Zhang, Q.-Y., Ye, X., Xu, X., & Yan, J. (2023) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17941 · Cited by 24
“11 Both mothers and foetuses with GDM are more likely to suffer from various short-and long-term adverse consequences than those of normal pregnancies.”
BackgroundLin, J., Zhao, D., Liang, Y., Liang, Z., Wang, M., Tang, X., Zhuang, H., Wang, H., Yin, X., Huang, Y., et al. (2024) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-024-06919-9 · Cited by 25
“Gestational diabetes mellitus (GDM) is a common pregnancy complication that refers to spontaneous hyperglycemia during pregnancy [1–3].”
BackgroundHuang, X., Yip, K. C., Nie, H., Chen, R., Wang, X., Wang, Y., Lin, W., & Li, R. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.3c00727 · Cited by 23
Jiang, D., He, J., Hua, S., Zhang, J., Liu, L., Shan, C., Cui, X., & Ji, C. (2022) · Molecular Omics · doi:10.1039/d2mo00083k · Cited by 22
Unique cardiometabolic factors in women that contribute to modified cardiovascular disease risk
Hetherington, K., Thomas, J., Nicholls, S. J., Barsha, G., & Bubb, K. J. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.177031 · Cited by 23
Kang, Y. E., Yi, H., Yeo, M., Kim, J. T., Park, D., Jung, Y. W., Kim, O. S., Lee, S. E., Kim, J. M., Joung, K. H., et al. (2022) · Journal of Korean Medical Science · doi:10.3346/jkms.2022.37.e338 · Cited by 21
Yang, X., & Wu, N. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s330323 · Cited by 22
“To ensure an adequate nutritional supply to the fetus, increased secretion of placental hormones is required, which leads to a physiological increase in IR in the mid-late gestation.(14) Pancreatic β-cell proliferation is a normal pregnancy phenomenon which leads to high fasting and postprandial blood glucose levels.”
BackgroundLackovic, M., Milicic, B., Mihajlovic, S., Filimonovic, D., Jurisic, A., Filipovic, I., Rovcanin, M., Prodanovic, M., & Nikolic, D. (2021) · Medicina · doi:10.3390/medicina57080741 · Cited by 18
“Some of these factors include overweight/obesity, advanced age of pregnant women, a positive family history of insulin resistance and/or diabetes and new “modern” lifestyle [2,3].”
BackgroundNon‐coding RNAs and their cross‐talks impacting reproductive health of women
Jain, N., Gupta, P., Sahoo, S., & Mallick, B. (2021) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1695 · Cited by 20
“Gestational diabetes mellitus (GDM) is another metabolic disorder of pregnancy that affects nearly 14% of pregnancies worldwide; however, it mostly gets resolved after pregnancy (Plows et al., 2018).”
BackgroundTanaka, T., Wada, T., Uno, K., Ogihara, S., Ie, H., Okekawa, A., Ishikawa, A., Ito, T., Miyazawa, Y., Sameshima, A., et al. (2021) · Diabetologia · doi:10.1007/s00125-021-05447-x · Cited by 21
“Insufficient insulin secretion in maternal adaptation is a factor in developing GDM [4, 5].”
BackgroundInfluentialda Costa, P. C. T., de Souza, E. L., Lacerda, D. C., Neto, J. P. R. C., de Sales, L. C. S., Silva-Luis, C. C., Pontes, P. B., Neto, M. P. C., & Alves, J. L. D. B. (2022) · Foods · doi:10.3390/foods11182772 · Cited by 22
“Oxidative stress and low-grade inflammation have been implicated in the pathogenesis of GDM [31,33].”
BackgroundThe crosstalk between cell death and pregnancy related diseases: A narrative review
Xie, X., Liu, J., Gao, J., Shang, C., Jiang, Y., Chen, L., Qian, Z., Liu, L., Wu, D., Zhang, Y., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116815 · Cited by 22
Etchegaray-Armijo, K., Bustos-Arriagada, E., Navarro-Rosenblatt, D., Vera, C. M., Garmendia, M. L., Sobrevía, L., López‐Alarcón, C., & Casanello, P. C. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.06.007 · Cited by 29
Predictors for insulin use in gestational diabetes mellitus
Ford, H. L., Champion, I., Wan, A., Reddy, M., Mol, B. W., & Rolnik, D. L. (2022) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2022.03.025 · Cited by 23
Oğlak, S. C., Yavuz, A., Ölmez, F., Özköse, Z. G., & Çaypınar, S. S. (2022) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2022.2083495 · Cited by 20
Zhang, L., Wang, P., Zhou, Y., Cheng, Y., Li, J., Xiao, X., Yin, C., Li, J., Meng, X., & Zhang, Y. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.159184 · Cited by 18
Tan, J., Chen, L., Wu, Y., Zhu, X., & Fei, H. (2023) · International Journal of General Medicine · doi:10.2147/ijgm.s423565 · Cited by 30
“%) strongly agreed or agreed with each of the statements in items A1–6, whereas around half of the participants strongly agreed or agreed that insulin therapy and other drug therapy for GDM are difficult to accept (item A7).”
BackgroundInfluentialZhang, H., Luan, S., Xiao, X., Lin, L., Zhao, X., & Liu, X. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118850 · Cited by 17
RetractedZhang, J., Xia, F., Song, Z., Guo, X., Lin, D., Jiang, F.-N., Lin, L., & Cai, Z. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1475212 · Cited by 25
Li, L., Wang, X., Chong, Y. S., Chan, J. K. Y., Tan, K. H., Eriksson, J. G., Huang, Z., Rahman, M. L., Liang, C., & Zhang, C. (2023) · BMC Medicine · doi:10.1186/s12916-023-02819-5 · Cited by 18
Sujan, M. A. J., Skarstad, H. M. S., Rosvold, G., Fougner, S. L., Nyrnes, S. A., Iversen, A., Follestad, T., Salvesen, K. Å., & Moholdt, T. T. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-073572 · Cited by 17
Cao, S., & Zhang, S. (2022) · Bioengineered · doi:10.1080/21655979.2021.2018094 · Cited by 17
“R As recommended by the International Association of Diabetes and Pregnancy Study Group (IADPSG), GDM is characterized by fasting plasma glucose (FPG) ≥ 92 mg/dL or glucose tolerance test (OGTT) 75 g within 2 h when FPG 92 mg/dL at the first prenatal visit [1].”
MethodRetractedNguyen, H. G., Huỳnh, N. K. T., & Nguyen, P. N. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13195895 · Cited by 26
“Particularly, the development of GDM pregnancy is an alert in low-middle income countries (LMICs) where assessment with the healthcare system remains limited, increasing to 20–25% in Southeast Asia [1,2].”
BackgroundSchiffer, V. M. M. M., Borghans, C. W. J., Arts, N., Bons, J. A. P., Severens‐Rijvers, C., van Kuijk, S. M. J., Spaanderman, M. E. A., & Al‐Nasiry, S. (2020) · Placenta · doi:10.1016/j.placenta.2020.10.035 · Cited by 18
Block, L. N., Bowman, B. D., Schmidt, J. K., Keding, L. T., Stanic, A. K., & Golos, T. G. (2020) · Biology of Reproduction · doi:10.1093/biolre/ioaa152 · Cited by 20
In Vivo and In Vitro Models of Diabetes: A Focus on Pregnancy
Lilao‐Garzón, J., Valverde‐Tercedor, C., Muñoz‐Descalzo, S., Brito‐Casillas, Y., & Wägner, A. M. (2020) · Advances in experimental medicine and biology · doi:10.1007/5584_2020_536 · Cited by 17
Gestational diabetes mellitus and COVID-19: The epidemic during the pandemic
Mendez, Y. H., Radilla, L. A., Chabolla, L. D., Cruz, A. C., Luna, J., & Surani, S. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i8.1178 · Cited by 18
Negotiating Gestational Diabetes Mellitus in India: A National Approach
Thanawala, U., Divakar, H., Jain, R. K., & Agarwal, M. (2021) · Medicina · doi:10.3390/medicina57090942 · Cited by 18
“However, in GDM, there is an inadequate compensation, due to multiple genetic and environmental factors, causing hyperglycemia [2].”
BackgroundBadu-Mensah, A., Valinski, P., Parsaud, H., Hickman, J. J., & Guo, X. (2022) · Cells · doi:10.3390/cells11223674 · Cited by 17
“Although the extent of hyperglycemia exposure during the fetal stage has not been well characterized, children born to GDM mothers have higher bodymass-indices and even greater risk of developing type 2 diabetes very early in life [47,48].”
BackgroundCardiac physiology and pathophysiology in pregnancy
Rizi, S. S., Wiens, E. J., Hunt, J., & Ducas, R. (2024) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2024-0010 · Cited by 35
Biete, M., & Vasudevan, S. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1420664 · Cited by 23
Advances in extracellular vesicles as mediators of cell-to-cell communication in pregnancy
Nair, S., Razo-Azamar, M., Jayabalan, N., Dalgaard, L. T., Palacios‐González, B., Sørensen, A., Kampmann, U., Handberg, A., Carrión, F., & Salomón, C. (2023) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2023.12.004 · Cited by 22
Huang, P., Deng, Y., Feng, L., Gao, Y., Cheng, X.-Q., & Liu, H. (2022) · Journal of Ultrasound in Medicine · doi:10.1002/jum.15994 · Cited by 21
“As a result, there is a vicious circle, leading to significant increase in blood glucose.(19) Correspondingly, blood glucose will increase in fetus of the mother with GDM, which will have a negative effect on fetal heart.”
BackgroundZhou, X., Li, J., Wei, L., He, M., Jia, J., Zhang, J., Wang, S., & Feng, L. (2020) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2000432 · Cited by 17
Gorban de Lapertosa, S., Sucani, S., Salzberg, S., Alvariñas, J., Faingold, C., Jawerbaum, A., Rovira, G., & on behalf of the DPSG-SAD Group (2021) · Health Care for Women International · doi:10.1080/07399332.2020.1800012 · Cited by 17
“…diagnosed for the first time during pregnancy (American Diabetes Association, 2009; Ben-Haroush et al., 2004; Kjos & Buchanan, 1999), is a prevalent and complex disease when considering both its etiology and pathophysiological mechanisms (Damm et al., 2016; Johns et al., 2018; Plows et al., 2018).”
BackgroundPlacental DNA methylation changes in gestational diabetes mellitus
Chen, F., Fei, X., Zhu, W., Zhang, Z., Shen, Y., Mao, Y., Zhu, Q., Xu, J., Zhou, W., Li, M., et al. (2022) · Epigenetics · doi:10.1080/15592294.2022.2110193 · Cited by 21
“Expectant mothers with an advanced maternal age (≥35 years), overweight, hyperglycaemic, or with a family history of type 2 diabetes (T2DM) are likely to experience difficulty in managing issues related to insulin sensitivity [4,5].”
BackgroundBittner, J. M. P., Gilman, S. E., Zhang, C., Chen, Z., & Cheon, B. K. (2023) · Annals of Epidemiology · doi:10.1016/j.annepidem.2023.08.002 · Cited by 21
Pan, M., Zhu, C., Ju, J., Xu, Y., Luo, S., Sun, S., & Ou, X. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30201 · Cited by 18
“Compared with the healthy pregnant women, the incidence of gestational diabetes is higher in obese pregnant women (Plows et al., 2018).”
BackgroundNeven, A. C. H., Mousa, A., Boyle, J. A., & Teede, H. J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.993619 · Cited by 36
“Reduced insulinstimulated glucose uptake further contributes to hyperglycemia which overburdens the b-cell, producing an additional insulin response and worsening b-cell dysfunction (5).”
BackgroundZaugg, J., López‐Tello, J., Musiał, B., Vaughan, O. R., Fowden, A. L., Albrecht, C., & Sferruzzi-Perri, A. N. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05192-5 · Cited by 26
“Despite this, the impacts of consuming a high fat and high sugar diet during pregnancy on fetal and offspring outcomes are poorly defined [15].”
BackgroundUnraveling the role of the gut microbiome in pregnancy disorders: insights and implications
Xie, Y., Chen, Q., Shan, D., Pan, X., & Hu, Y. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1521754 · Cited by 20
“In terms of pathophysiology, the main aberrations in GDM are chronic in fl ammation, insulin resistance, and pancreatic islet b cell dysfunction (Plows et al., 2018).”
LeMay‐Nedjelski, L., Yonemitsu, C., Asbury, M. R., Butcher, J., Ley, S. H., Hanley, A. J., Kiss, A., Unger, S. L., Copeland, J. K., Wang, P. W., et al. (2021) · Journal of Nutrition · doi:10.1093/jn/nxab270 · Cited by 17
The pathologic changes of human placental macrophages in women with hyperglycemia in pregnancy
Ning, J., Zhang, M., Cui, D., & Yang, H. (2022) · Placenta · doi:10.1016/j.placenta.2022.11.004 · Cited by 18
Montero, C. G., Fraile‐Μartinez, O., Rodriguez-Martín, S., Saz, J. V., Rodríguez, R. A., Moreno, J. M. P., Ruiz-Labarta, J., García‐Honduvilla, N., Álvarez‐Mon, M., Bravo, C., et al. (2023) · Foods · doi:10.3390/foods12061148 · Cited by 18
“Women with GDM exhibit pancreatic β-cell dysfunction on a background of chronic insulin resistance during pregnancy, along with changes in other systems and organs [26].”
BackgroundZhang, M., Li, Q., Wang, K.-L., Dong, Y., Mu, Y., Cao, Y.-M., Liu, J., Li, Z., Cui, H.-L., Liu, H., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-03902-4 · Cited by 17
Gestational diabetes mellitus placentas exhibit epimutations at placental development genes
Meyrueix, L. P., Gharaibeh, R. Z., Xue, J., Brouwer, C., Jones, C. D., Adair, L. S., Norris, S. A., & Ideraabdullah, F. (2022) · Epigenetics · doi:10.1080/15592294.2022.2111751 · Cited by 19
“In most cases, GDM is caused by pancreatic β-cell dysfunction [4], which leads to chronic insulin resistance [5] and subsequent hyperglycaemia[6].”
BackgroundWang, C., Zhang, X., Liu, M., Qin, S., He, C., Liu, Y., Jing, H., Zhang, Q.-D., Wei, Y.-M., & Yang, H. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1034443 · Cited by 15
Chopra, D., Shukla, S., Rana, P., Kamar, M. D., Gaur, P., Bala, M., & Pathaniya, D. (2024) · Springer eBooks · doi:10.1007/978-981-97-0157-5_1 · Cited by 29
Tauber, Z., Burianova, A., Koubova, K., Mrstik, M., Jirkovská, M., & Čížková, K. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1386528 · Cited by 19
Perinatal Outcomes of Women Aged 50 Years and Above
Maoz-Halevy, E., Pariente, G., Sheiner, E., & Wainstock, T. (2019) · American Journal of Perinatology · doi:10.1055/s-0039-1700859 · Cited by 16
A longitudinal cohort study of gestational diabetes mellitus and perinatal depression
Li, H., Yu, X., Qiang, W., Lu, M., Jiang, M., Hou, Y., Gu, Y., Tao, F., & Zhu, B. (2022) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-022-04667-2 · Cited by 22
Postnatal care after gestational diabetes – a systematic review of clinical practice guidelines
Ohene‐Agyei, P., Iqbal, A., Harding, J. E., Crowther, C. A., & Lin, L. (2024) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-024-06899-w · Cited by 23
“Additionally, some of the medical contraindications to hormonal contraceptives such as older age, cardiovascular risk factors, and high BMI [79], are also risk factors commonly found in women who develop GDM [4].”
BackgroundLi, N., Liu, H., & Liu, S.-M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179361 · Cited by 19
“…physiological phenomenon in which, under the influence of hormonal changes (placental growth hormone, placental trophins, steroids, etc.), the cell’s response to insulin is reduced, while the pancreatic β -cells compensate for increased insulin secretion to maintain normal blood glucose levels [11].”
BackgroundO-GlcNAcylation in Hyperglycemic Pregnancies: Impact on Placental Function
Ning, J., & Yang, H. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.659733 · Cited by 19
“This may affect numerous cellular pathways, leading to accumulation of advanced glycation end-products (4, 5) and induction of oxidative stress (6).”
BackgroundErbağcı, M. O., Tuna, G., Köse, S., Dal-Bekar, N. E., Akış, M., Kant, M., Altunyurt, S., & İşlekel, H. (2021) · Reproductive Toxicology · doi:10.1016/j.reprotox.2021.05.009 · Cited by 17
UCN2: a new candidate influencing pancreatic β-cell adaptations in pregnancy
Simpson, S., Smith, L. I. F., Jones, P. M., & Bowe, J. E. (2020) · Journal of Endocrinology · doi:10.1530/joe-19-0568 · Cited by 16
Nikparast, A., Rahmani, J., Bagheri, R., Mohammadpour, S., Shadnoosh, M., Wong, A., & Ghanavati, M. (2023) · Journal of Diabetes Investigation · doi:10.1111/jdi.14022 · Cited by 21
Zhang, Y., Ye, S., Li, Y., Chen, J., & Zhang, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.739511 · Cited by 16
“The elevated blood glucose levels stimulate a compensatory increase in the release of insulin, and there is an adaptive increase in pancreatic β-cell mass caused by increased cell proliferation and reduced apoptosis (Plows et al., 2018).”
BackgroundWang, Y., Wang, H., & Yang, F. (2020) · Dose-Response · doi:10.1177/1559325820984910 · Cited by 18
“women.(34) Our bd/þ mice model also presented maternal dyslipidemia with increased cholesterol, triglycerides, and LDL levels and decreased HDL level.”
BackgroundKhobrani, M. A., Kandasamy, G., Vasudevan, R., et al. (2023) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2023.03.005 · Cited by 16
“Measurements of plasma pyridoxal or total vitamin B6 and urinary 4-pyridoxic acid are other techniques (Plows et al., 2018).”
Sun, J., Chai, S., Zhao, X., Yuan, N., Du, J., Liu, Y., Li, Z., & Zhang, X. (2021) · Journal of Diabetes Research · doi:10.1155/2021/5537110 · Cited by 19
Dissassa, H. D., Girma, D., Geleta, L. A., Dabalo, Y. A., & Oyato, B. T. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-073339 · Cited by 24
Gut Microbiota Associated with Gestational Health Conditions in a Sample of Mexican Women
Benítez-Guerrero, T., Vélez-Ixta, J. M., Juárez-Castelán, C. J., Corona-Cervantes, K., Piña-Escobedo, A., Martínez-Corona, H., Sales-Millán, A. D., Cruz‐Narváez, Y., Gómez-Cruz, C. Y., Ramírez-Lozada, T., et al. (2022) · Nutrients · doi:10.3390/nu14224818 · Cited by 19
“Associated complications comprise pre-eclampsia, postpartum infection, antenatal depression [23], metabolic syndrome [20], and cardiovascular diseases [24].”
BackgroundJung, Y., Lee, S. M., Lee, J., Kim, Y., Lee, W., Koo, J. N., Oh, I. H., Kang, K. H., Kim, B. J., Kim, S. M., et al. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02645-4 · Cited by 20
Guevara‐Ramírez, P., Paz‐Cruz, E., Cadena-Ullauri, S., Ruiz‐Pozo, V. A., Tamayo‐Trujillo, R., Felix, M. L., Simancas‐Racines, D., & Zambrano, A. K. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1228703 · Cited by 26
Educational Review: The Impact of Perinatal Oxidative Stress on the Developing Kidney
DeFreitas, M. J., Katsoufis, C. P., Benny, M., Young, K. C., Kulandavelu, S., Ahn, H., Sfakianaki, A. K., & Abitbol, C. L. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.853722 · Cited by 17
“This hyperglycemic environment is thought to provoke placental oxidative stress and dysfunction, and GDM women have been reported to overproduce free radicals and have impaired free-radical scavenging mechanisms (35).”
BackgroundGundacker, C., & Ellinger, I. (2020) · Reproductive Toxicology · doi:10.1016/j.reprotox.2020.07.014 · Cited by 21
Regulatory mechanisms and pathological implications of CYP24A1 in Vitamin D metabolism
Milan, K. L., & Ramkumar, K. M. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155684 · Cited by 22
Álvarez-Silvares, E., Fernández-Cruz, T., Domínguez-Vigo, P., Rubio-Cid, P., Seoane-Pillado, T., & Martínez-Carballo, E. (2021) · Environmental science and pollution research international · doi:10.1007/s11356-021-12377-z · Cited by 12
Xiao, Y., Ding, J., Shi, Y., Lin, L., Huang, W., Shen, D., & Wang, W. (2020) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.14249 · Cited by 17
“In this current study, we proposed to study the effects and mechanisms of miR-330-3p in GDM.”
BackgroundInfluentialYang, X., & Wu, N. (2022) · Dove Medical Press (Taylor and Francis Group) · Cited by 15
Targeted and untargeted metabolomic approach for GDM diagnosis
Burzyńska-Pędziwiatr, I., Dudzik, D., Sansone, A., Małachowska, B., Zieleniak, A., Żurawska-Kliś, M., Ferreri, C., Chatgilialoglu, C., Cypryk, K., Woźniak, L. A., et al. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.997436 · Cited by 21
“, developing type 2 diabetes (T2DM) cardiovascular diseases (CVD), obesity, or hyperlipidemia (Nezami et al., 2010; Plows et al., 2018).”
BackgroundCushing’s Syndrome and Other Causes of Insulin Resistance in Dogs
Fleeman, L. M., & Barrett, R. (2023) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2023.01.009 · Cited by 28
Li, J., Wang, M., Ma, S., Jin, Z., Yin, H., & Yang, S. (2024) · Nutrition and Diabetes · doi:10.1038/s41387-024-00291-5 · Cited by 23
“Obesity can also affect GDM through other mechanisms, including impaired β -cell function and chronic low-grade in fl ammation [93, 94].”
BackgroundThe Relationship between Angiogenic Factors and Energy Metabolism in Preeclampsia
Abascal-Saiz, A., Duque-Alcorta, M., Fioravantti, V., Antolin, E., Fuente-Luelmo, E., Haro, M., Ramos, P., Perdomo, G., & Bartha, J. L. (2022) · Nutrients · doi:10.3390/nu14102172 · Cited by 18
Houttu, N., Mokkala, K., Koivuniemi, E., Pellonperä, O., Juhila, J., Sorsa, T. A., & Laitinen, K. (2020) · Biomolecules · doi:10.3390/biom11010005 · Cited by 16
“Both increased low-grade inflammation and higher adiposity have been linked to gestational diabetes mellitus (GDM) [1], which is a serious condition in pregnancy, increasing the risk of metabolic complications in both mother and child.”
Impact of adverse pregnancy outcomes on brain vascular health and cognition
Wolfová, K., & Miller, E. C. (2024) · Research and Practice in Thrombosis and Haemostasis · doi:10.1016/j.rpth.2024.102331 · Cited by 17
“Gestational diabetes is caused by a dysfunction of pancreatic β -cells on a background of chronic insulin resistance during pregnancy [10].”
BackgroundHart, K. H., Hill, A., Gonzalez, J. T., de la Hunty, A., Gallagher, A. M., & Stanner, S. A. (2025) · Nutrition Bulletin · doi:10.1111/nbu.70016 · Cited by 33
“Many countries have observed a rapid increase in the prevalence rates, with global prevalence reported as 14% (Plows et al. 2018; Wang et al. 2022); however, prevalence rates vary due to variation in screening strategies and diagnostic criteria (Wang et al. 2022).”
Amirani, E., Asemi, Z., Asbaghi, O., Milajerdi, A., Reiner, Ž., Mansournia, M. A., Hallajzadeh, J., Moazzami, B., & Chaichian, S. (2020) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00558-5 · Cited by 18
“Increased maternal insulin resistance plays a central role in the pathogenesis of GDM which is not a rare complication of pregnancy [38].”
BackgroundLiu, K., Gu, Y., Pan, X., Chen, S., Cheng, J., Zhang, L., & Cao, M. (2024) · iScience · doi:10.1016/j.isci.2024.111019 · Cited by 18
“21 Toll-like receptor (TLRs) family members play a pivotal role in the formation of chronic inflammation and IR.”
The role of placenta Hofbauer cells during pregnancy and pregnancy complications
Yang, S.-W., Hwang, H. S., & Kang, Y. (2024) · Obstetrics & Gynecology Science · doi:10.5468/ogs.24247 · Cited by 17
Kupai, K., Várkonyi, T. T., Török, S., Gáti, V., Czimmerer, Z., Puskás, L. G., & Szebeni, G. J. (2022) · Life · doi:10.3390/life12081205 · Cited by 19
“GDM can be controlled with a low carbohydrate diet and/or insulin administration during pregnancy, and glucose metabolism should be regularly monitored after delivery because it can develop into persistent T2DM and even cardiovascular disease (CVD) in the mother and/or in the descendant [8].”
BackgroundZhang, H., Jiang, Y., Zhu, S., Wei, L., Zhou, X., Gao, P., Zhang, J., Chen, Y., Du, Y., Fang, C., et al. (2024) · Placenta · doi:10.1016/j.placenta.2024.01.011 · Cited by 18
Greff, D., Váncsa, S., Váradi, A., Szinte, J., Park, S., Hegyi, P., Nyírády, P., Ács, N., Horvath, E. M., & Várbíró, S. (2023) · Nutrients · doi:10.3390/nu15194224 · Cited by 18
“GDM develops when β -cell function is insufficient to overcome the chronic insulin resistance associated with pregnancy [14].”
BackgroundArtificial Intelligence in Human Reproduction
Mendizabal‐Ruiz, G., Paredes, O., Álvarez, Á., Gomez, F. J. A., Hernández-Morales, E., González-Sandoval, J., Mendez-Zavala, C., Borrayo, E., & Chávez-Badiola, A. (2024) · Archives of Medical Research · doi:10.1016/j.arcmed.2024.103131 · Cited by 18
Perkovic-Kepeci, S., Cirkovic, A. M., Milic, N. M., Dugalić, S., Stanisavljevic, D. M., Milinčić, M., Kostić, K., Milic, N., Todorović, J., Marković, K., et al. (2023) · Medicina · doi:10.3390/medicina59081502 · Cited by 24
“Peixoto (2016) [14] Brazil retrospective cohort study UA-PI MCA-PI UtA-PI GDM 56 Pregnant women who underwent 3rd-trimester ultrasound”
BackgroundShen, S., Žurauskienė, J., Wei, D., Chen, N., Lu, J., Kuang, Y., Liu, H., Cazier, J., & Qiu, X. (2021) · Endocrine · doi:10.1007/s12020-021-02787-x · Cited by 17
Metadata
- Authors
- Plows, J. F., Stanley, J. L., Baker, P. N., Reynolds, C. M., & Vickers, M. H.
- Affiliations
- University of Southern California (US)
- University of Auckland (NZ)
- University of Leicester (GB)
- Corresponding author
- Vickers, Mark H
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-10-26
- Volume
- 19
- Issue
- 11
- Pages
- 3342
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6274679
- OpenAlex
- W2898266729
- Cited by
- 1,874
- References
- 175
- Citations by year
- 2026: 277 · 2025: 298 · 2024: 319 · 2023: 307 · 2022: 295 · 2021: 221 · 2020: 122 · 2019: 33
- FWCI
- 15.21
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UEA Digital Repository (University of East Anglia) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Leicester Research Archive (University of Leicester) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Keywords
- gestational diabetes mellitus, pathophysiology, hyperglycemia in pregnancy, impaired glucose tolerance, beta-cell dysfunction, insulin resistance, maternal obesity, type 2 diabetes risk, macrosomia, cardiovascular risk, GDM prevention, insulin therapy, lifestyle intervention
- MeSH terms
- Adipose Tissue, Animals, Female, Glucose, Humans, Insulin Resistance, Pregnancy, Risk Factors, Diabetes, Gestational, Oxidative Stress, Leptin, Insulin-Secreting Cells, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.